AngioDynamics EBITDA 2010-2024 | ANGO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

AngioDynamics ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

AngioDynamics ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$216B
Thermo Fisher Scientific (TMO)	$205.7B
Alcon (ALC)	$44.2B
Edwards Lifesciences (EW)	$44.1B
IDEXX Laboratories (IDXX)	$37.1B
DexCom (DXCM)	$34.9B
IQVIA Holdings (IQV)	$34.2B
Mettler-Toledo (MTD)	$27.3B
Waters (WAT)	$22.6B
STERIS (STE)	$21.7B
SONOVA HOLDING (SONVY)	$19.3B
Hologic (HOLX)	$14.4B
Fresenius Medical Care AG KGaA (FMS)	$13.5B
Penumbra (PEN)	$11.7B
Sysmex ADR (SSMXY)	$11.5B
Globus Medical (GMED)	$11.5B
Masimo (MASI)	$9.5B
Glaukos (GKOS)	$8.7B
Teleflex (TFX)	$8.1B
Inari Medical (NARI)	$4.7B
Integer Holdings (ITGR)	$4.5B
PROCEPT BioRobotics (PRCT)	$3.4B
Veracyte (VCYT)	$3.2B
Nihon Kohden (NHNKY)	$2.7B
LivaNova (LIVN)	$2.6B
TransMedics (TMDX)	$2.5B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2.1B
Integra LifeSciences Holdings (IART)	$1.7B
Alphatec Holdings (ATEC)	$1.5B